Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras

International Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 118-124

  Feldkamp, Matthias M ^a,b   Lau, Nelson ^a   Rak, Janusz ^c   Kerbel, Robert S ^c   Guha, Abhijit ^a,b,d,e  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 [[2 [(2 AMINO 3 MERCAPTOPROPYL)AMINO] 3 METHYLPENTYL]OXY] 1 OXO 3 PHENYLPROPYL]AMINO] 4 (METHYLSULFONYL)BUTANOIC ACID ISOPROPYL ESTER; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; ASTROCYTOMA CELL; CANCER GROWTH; CONTROLLED STUDY; ENZYME ACTIVATION; GENE ACTIVATION; GENE MUTATION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYPOXIA; MALIGNANT TRANSFORMATION; ONCOGENE RAS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

3T3 CELLS; ANIMALS; ASTROCYTOMA; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; MICE; ONCOGENES; OXYGEN; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033051030     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.0.CO;2-5     Document Type: Article

References (25)

1. ARBISER, J.L., MOSES, M.A., FERNANDEZ, C.A., GHISO, N., CAO, Y., KLAUBER, N., FRANK, D., BROWNLEE, M., FLYNN, E., PARANGI, S., BYERS, H.R. and FOLKMAN, J., Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc. nat. Acad. Sci. (Wash.), 94, 861-866 (1997).
2. COHEN, T., GITAY-GOREN, H., SHARON, R., SHIBUYA, M., HALABAN, R., LEVI, B.Z. and NEUFELD, G., VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J. biol. Chem., 270, 11322-11326 (1995).
3. FINKENZELLER, G., TECHNAU, A. and MARMÉ, D., Hypoxia induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. biophys. Res. Comm., 208, 432-439 (1995).
4. FOLKMAN, J., Tumor angiogenesis and tissue factor. Nature (Med.), 2, 167-168 (1996).
5. FONG, T.AT., MCMAHON, G., KIM, Y., SUN, L., TANG, C., CHEN, J., SUTTON, B., SCHRECK, R., SMOLICH, B., JACOBS, J. and SHAWVER, L.K., Small molecule inhibitors of Flk-1 suppress subcutaneous growth of multiple tumor types, inhibit tumor angiogenesis, and provide attenuation of metastases. Proc. Amer. Ass. Cancer Res., 38, 266 (1997).
6. GOLDMAN, C.K., KIM, J., WONG, W.L., KING, V., BROCK, T. and GILLESPIE, G.Y., Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell, 4, 121-133 (1993).
7. GOSPODAROWICZ, D., ABRAHAM, J.A. and SCHILLING, J., Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. nat. Acad. Sci. (Wash.), 86, 7311-7315 (1989).
8. GRUGEL, S., FINKENZELLER, G., WEINDEL, K., BARLEON, B. and MARMÉ, D., Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. biol Chem., 270, 25915-25919 (1995).
9. GUHA, A., FELDKAMP, M.M., LAU, N., BOSS, G. and PAWSON, T., Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene. 15, 2755-2766 (1997).
10. HOUCK, K.A., FERRARA, N., WINER, J., CACHIANES, G., LI, B. and LEUNG, D.W., The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol., 5, 1806-1814 (1991).
11. LARCHER, F., ROBLES, A.I., DURAN, H., MURILLAS, R., QUINTANILLA, M., CANO, A., CONTI, C.J. and JORCANO, J.L., Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res., 56, 5391-5396 (1996).
12. LEVY, A.P., LEVY, N.S. and GOLDBERG, M.A., Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. biol. Chem., 271, 2746-2753 (1996).
13. MAZURE, N.M., CHEN, E.Y., LADEROUTE, K.R. and GIACCIA, A.J., Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinosilol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood, 90, 3322-3331 (1997).
14. MILLAUER, B., SHAWVER, L.K., PLATE, K.H., RISAU, W. and ULLRICH, A., Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367, 576-579 (1994).
15. MIYAKE, M., MIZUTANI, S., KOIDE, H. and KAZIRO, Y., Unfarnesylated transforming Ras mutant inhibits the Ras-signaling pathway by forming a stable Ras.Raf complex in the cytosol. FEBS Lett., 378, 15-18 (1996).
16. NISHIKAWA, R., JI, X., HARMON, R.C., LAZAR, C.S., GILL, G.N., CAVENEE, W.K. and HUANG, H.J., A mutant epidermal growth factor receptor common in human gliomas confers enhanced tumorigenicity. Proc. nat. Acad. Sci. (Wash.), 91, 7727-7731 (1994).
17. OKADA, F., RAK, J.W., CROIX, B.S., LIEUBEAU, B., KAYA, M., RONCARI, L., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R.S., Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. Proc. nat. Acad. Sci. (Wash.), 95, 3609-3614 (1998).
18. PETIT, A.M., RAK, J., HUNG, M.C., ROCKWELL, P., GOLDSTEIN, N., FENDLY, B. and KERBEL, R.S., Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. Amer. J. Pathol., 151, 1523-1530 (1997).
19. PLATE, K.H., BREIER, G., WEICH, H.A., MENNEL, H.D. and RISAU, W., Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59, 520-529 (1994).
20. PLATE, K.H., BREIER, G., WEICH, H.A. and RISAU, W., Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359, 845-848 (1992).
21. RAK, J., MITSUHASHI, Y., BAYKO, L., FILMUS, J., SHIRASAWA, S., SASAZUKI, T. and KERBEL, R., Mutant ras oncogenes upregulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res., 55, 4575-4580 (1995).
22. SALEH, M., STACKER, S.A. and WILKS, A.F., Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56, 393-401 (1996).
23. STECK, P.A., LEE, P., HUNG, M.C. and YUNG, W.K., Expression of an altered epidermal growth factor receptor by human glioblastoma cells. Cancer Res.. 48, 5433-5439 (1988).
24. TUZI, N.L., UENTER, D.J., KUMAR, S., STADDON, S.L., LEMOINE, N.R. and GULLICK, W.J., Expression of growth factor receptors in human brain tumours. Brit. J. Cancer, 63, 227-233 (1991).
25. VOLPERT, O.V., DAMERON, K.M. and BOUCK, N., Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity. Oncogene, 14, 1495-1502 (1997).